UIA
CVS icon

Ulland Investment Advisors’s CVS Health CVS Stock Holding History

Ulland Investment Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Hold
11
– – ﹤0.01% 222
2026
Q1 		$1K Hold
11
– – ﹤0.01% 207
2025
Q4 		$1K Hold
11
– – ﹤0.01% 209
2025
Q3 		$1K Sell
11
-300
-96% -$20.6K ﹤0.01% 221
2025
Q2 		$21K Sell
311
-50
-14% -$3.28K 0.02% 145
2025
Q1 		$24K Sell
361
-1,435
-80% -$85.9K 0.02% 142
2024
Q4 		$81K Hold
1,796
– – 0.05% 94
2024
Q3 		$113K Sell
1,796
-560
-24% -$32.7K 0.08% 72
2024
Q2 		$139K Buy
2,356
+750
+47% +$46.9K 0.1% 71
2024
Q1 		$128K Hold
1,606
– – 0.1% 78
2023
Q4 		$127K Sell
1,606
-250
-13% -$17.8K 0.13% 68
2023
Q3 		$130K Buy
1,856
+375
+25% +$26.6K 0.14% 63
2023
Q2 		$102K Buy
1,481
+370
+33% +$26.3K 0.1% 78
2023
Q1 		$83K Buy
1,111
+1,010
+1,000% +$84.7K 0.1% 74
2022
Q4 		$9K Sell
101
-40
-28% -$3.86K 0.01% 160
2022
Q3 		$13K Hold
141
– – 0.01% 154
2022
Q2 		$13K Hold
141
– – 0.01% 164
2022
Q1 		$14K Hold
141
– – 0.01% 173
2021
Q4 		$15K Buy
+141
New +$13K 0.01% 159

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Ulland Investment Advisors's CVS Position: Q2 2026 in Review

Ulland Investment Advisors held its CVS Health (CVS) position steady in Q2 2026 at 11 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #222.

Ulland Investment Advisors first reported a position in CVS in Q4 2021 and has held it in 19 quarters since. The position peaked at $139K in Q2 2024. 2,074 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Ulland Investment Advisors held 11 shares of CVS Health worth $1K as of Q2 2026.
  • Ulland Investment Advisors left its CVS Health share count unchanged in Q2 2026.
  • CVS Health made up ﹤0.01% of Ulland Investment Advisors's portfolio in Q2 2026, its #222 holding.
  • Ulland Investment Advisors first reported a position in CVS Health in Q4 2021 and has held it in 19 quarters since.
  • Ulland Investment Advisors's CVS Health position peaked at $139K in Q2 2024.
  • 2,074 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Ulland Investment Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.